C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 491/048 (2006.01) A61K 31/506 (2006.01) A61K 51/00 (2006.01) A61K 51/04 (2006.01) C07D 491/04 (2006.01) G01N 33/566 (2006.01) G01N 33/60 (2006.01)
Patent
CA 2454228
The present invention is directed to radiolabeled neuropeptide Y Y5 receptor antagonists of the formula: (see above formula) which can be labeled with a radionuclide selected from the group consisting of: 3H, 11C, 18F, 15O and 13 N; analogs of this compound could be labeled with 1251, 123I, 131I, 75Br, 15O, 13N, 211At, 82Br, 77Br or 76Br; particular antagonists include [11C] trans-N-[5-(2-fluorophenyl)-2-pyrimidinyl]-3-oxospiro[5- azaisobenzofurane-1(3H),1'-cyclohexane]-4'-carboxamide and [18F] trans-N-[5-(2- fluorophenyl)-2-pyrimidinyl]-3-oxospiro[5-azaisobenzofurane-1(3H),1'- cyclohexane]- 4'-carboxamide and pharmaceutically acceptable salts thereof; the antagonists are useful for the labeling and diagnostic imaging of neuropeptide Y Y5 receptors in mammals.
L'invention concerne des antagonistes radiomarqués du récepteur Y5 du neuropeptide Y, qui sont utiles pour le marquage et l'imagerie de diagnostic des récepteurs Y5 du neuropeptide Y chez les mammifères.
Burns H. Donald
Fukami Takehiro
Gibson Raymond E.
Hamill Terence G.
Banyu Pharmaceutical Co. Ltd.
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Msd K.k.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Radiolabeled neuropeptide y y5 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiolabeled neuropeptide y y5 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled neuropeptide y y5 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1564724